StockData
Omeros Corp logo

Omeros Corp (OMER) stock

OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$13.21−0.80 (-5.71%)

Close on Nov 20, 2026Market cap $956.25MP/E –Yield –

Omeros gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Omeros's gross profit for the twelve months ending Mar 31, 2021 was $70.44M, down 37.4% year over year. For fiscal 2020 it was $72.91M, down 34.3% from the year before. The highest annual figure on record is $110.94M in fiscal 2019.

Annual gross profit

PeriodPeriod endValueChange
FY2020Dec 31, 2020$72.91M-34.3%
FY2019Dec 31, 2019$110.94M+277.9%
FY2018Dec 31, 2018$29.36M-53.9%
FY2017Dec 31, 2017$63.75M+58.6%
FY2016Dec 31, 2016$40.21M+222.5%
FY2015Dec 31, 2015$12.47M+2213.2%
FY2014Dec 31, 2014$539.00K-66.3%
FY2013Dec 31, 2013$1.60M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$27.73M+33.3%
Q1 FY2026Mar 31, 2026$9.31M-11.7%
Q2 FY2025Jun 30, 2025$0-100.0%
Q1 FY2025Mar 31, 2025$0-100.0%
Q1 FY2021Mar 31, 2021$20.80M-10.6%
Q4 FY2020Dec 31, 2020$10.55M-68.1%
Q3 FY2020Sep 30, 2020$25.71M-13.1%
Q2 FY2020Jun 30, 2020$13.38M-49.9%
Q1 FY2020Mar 31, 2020$23.27M+7.5%
Q4 FY2019Dec 31, 2019$33.02M+51.0%
Q3 FY2019Sep 30, 2019$29.58M+546.9%
Q2 FY2019Jun 30, 2019$26.70M+1634.8%
Q1 FY2019Mar 31, 2019$21.65M+1463.0%
Q4 FY2018Dec 31, 2018$21.86M+64.4%
Q3 FY2018Sep 30, 2018$4.57M-78.7%
Q2 FY2018Jun 30, 2018$1.54M-90.9%
Q1 FY2018Mar 31, 2018$1.39M-88.4%
Q4 FY2017Dec 31, 2017$13.30M+6.1%
Q3 FY2017Sep 30, 2017$21.47M+96.8%
Q2 FY2017Jun 30, 2017$16.99M+75.6%
Q1 FY2017Mar 31, 2017$11.99M–
Q4 FY2016Dec 31, 2016$12.53M–
Q3 FY2016Sep 30, 2016$10.91M–
Q2 FY2016Jun 30, 2016$9.68M–

More Omeros figures

See a number that looks wrong?